2023
DOI: 10.1111/omi.12411
|View full text |Cite
|
Sign up to set email alerts
|

Small noncoding RNA in Streptococci: From regulatory functions to drug development

Abstract: Streptococci are a genus of gram‐positive coccus of spherical bacteria, including many commensal bacteria and opportunistic pathogens that threaten the public health system. Small noncoding RNAs (sRNAs) are a class of noncoding RNAs regulating gene expression via various regulatory mechanisms, which have been illustrated to play vital roles in regulations of virulence factor expressions. Recent advances in sequencing technology and bioinformatic analysis facilitated discovery of a myriad of sRNAs from pathogen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 99 publications
0
1
0
Order By: Relevance
“…RNA-based therapies, including mRNA and small interfering RNA (siRNA), have attracted considerable attention in recent years as they enable modulation of gene expression compared to conventional methods and offer opportunities for personalized medicine ( Kwok et al., 2019 ). Significant structural investigations have been conducted on RNA motifs and/or RNA-protein complexes, which aid drug development through structure-based virtual screening ( Yang et al., 2023 ). The effectiveness of these new systems depends on the specific application, the nature of the drug, and the disease or condition in question.…”
Section: Discussionmentioning
confidence: 99%
“…RNA-based therapies, including mRNA and small interfering RNA (siRNA), have attracted considerable attention in recent years as they enable modulation of gene expression compared to conventional methods and offer opportunities for personalized medicine ( Kwok et al., 2019 ). Significant structural investigations have been conducted on RNA motifs and/or RNA-protein complexes, which aid drug development through structure-based virtual screening ( Yang et al., 2023 ). The effectiveness of these new systems depends on the specific application, the nature of the drug, and the disease or condition in question.…”
Section: Discussionmentioning
confidence: 99%